APA (7th ed.) Citation

WR, C., PL, L., CC, H., JY, C., LY, L., MI, S., . . . YH, L. (2023). Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation. Scientific reports, 13(1), 3961. https://doi.org/10.1038/s41598-023-30971-8

Chicago Style (17th ed.) Citation

WR, Chiou, et al. "Author Correction: Rhythm Control Without Catheter Ablation May Have Benefits Beyond Stroke Prevention in Rivaroxaban-treated Non-permanent Atrial Fibrillation." Scientific Reports 13, no. 1 (2023): 3961. https://doi.org/10.1038/s41598-023-30971-8.

MLA (9th ed.) Citation

WR, Chiou, et al. "Author Correction: Rhythm Control Without Catheter Ablation May Have Benefits Beyond Stroke Prevention in Rivaroxaban-treated Non-permanent Atrial Fibrillation." Scientific Reports, vol. 13, no. 1, 2023, p. 3961, https://doi.org/10.1038/s41598-023-30971-8.